our business

Gynecological

Industry leader addressing women’s health issues

• 55% of women in India are anemic
• Emcure’s mission is to make India anemia free
• Emcure is associated with the launch of Ferric carboxymaltose & Ferrous Ascorbate for the first time in India
• Presence in all key segments: Iron Deficiency, Pregnancy care, Dysmenorrhea, Heamostats, Infertility & Feminine Hygiene

• In blood related anti-anemic segment, Emcure also has its presence through Vintor, Eporise & Epofer
• Emcure is ranked #1 in Heamostats and has introduced renowned brands such as Pause and Sylate, which are non-hormonal therapies that are used widely to stop menstrual bleeding and associated pain
• In relation to infertility, Emcure is on a mission to nurture and support ART (assisted reproductive technology) with brands such as Materna, Ciscure, Emprogest and Exhep that assure quality, better patient compliance and affordable IVF cycles
• Emcure’s presence in feminine hygiene is led by Lactacyd (in-licensed from Sanofi) which is an ideal perineal wash recommended by gynecologists worldwide
• Emcure has recently launched Dydrofem (Dydrogesterone) indicated for a variety of indications, including threatened or recurrent miscarriage during pregnancy, dysfunctional bleeding, infertility due to luteal insufficiency and dysmenorrhea
• Post-delivery for lactating mothers, Emcure has created Galact which is the #1 Galactogogue, a Shatavari based formulation with a taste that scores over others

Cardiology

Pioneers in Chirality

• Deep routed presence in Hypertension, Anti-Thrombotic and lipid regulators

• For hypertension, Emcure has pioneered the concept of chirality and has reinvigorated focus in cardiology. It has strengthened the hypertension portfolio with the introduction of more brands such as Asomex, S-Numlo, Temsan, Efnocar and Zilarbi
• In Anti-thrombotics, Emcure has products such as Exhep, Enoxarin, Lomoh and Elaxim that offer cardio protection in emergency situations such as myocardial infarction. Lomoh is a globally known brand with par excellence quality helping in lowering mortality and morbidity. Elaxim is Emcure’s market leading 3rd Gen Thrombolytic, Fibrin specific tissue plasminogen activator
• Under anti-coagulants, two of its eight brands (Exhep & Enoxarin) are listed in the Top 300 Brands in the IPM. Emcure is constantly working towards upscaling the production and availability of these anti-coagulants for COVID- 19 patients
• Newly launched Exafib developed in-house is enabling to strengthen Emcure’s anti-coagulant portfolio further
• Lipid regulators, Atorec & Consivas empower the coronary segment by avoiding high cardio-vascular risk. These drugs are affordable solutions as treatment for dyslipidemia

Antivirals

Leaders in the global fight against HIV

• Multiple first time introductions in India; Committed to HIV care

Vitamins

Supplementing Health

• Emcure has a wide range of products available under oral, liquid and injectables

• Bevon is one of the 8 brands listed in the Top 300 Brands in the IPM
• The Hosit range helps to fulfil the nutritional requirements of diabetic patients and is beneficial as a neuroprotective for them

Pain/ Analgesics

Chirally Pure Brand

• Emanzen D is developed with double enteric coating cold technology that ensures rapid pain relief, powerful anti-inflammatory response while being gentle to the gastro intestinal tract

• Chirally pure brands such as Proxym, Setolac and Infen are specialists that reduce pain and inflammation. These deliver better safety, efficacy and less metabolic load that make them advantageous compared to other NSAIDS
• Emcure has newly launched, Fitjoint Max which is a nutritional supplement for Osteoarthritis

Anti- neoplastic

Strong Biologics Portfolio

• Emcure is one of the fastest growing company in this highly specialized therapy

• Strong portfolio of inhouse developed biologics
• 1st time in India launch of PegAsparginese under Hamsyl brand
• It is emerging as an upcoming focus area with brands such as Oxa and Citafine for colorectal cancer that are effective in antineoplastic therapy
• Emcure has one of the largest portfolio in the oncology segment which includes Eligard (in-licensed form Tolmar), Taxotere, Jevtana and Fludara (in-licensed from Sanofi)

Diabetes

Emerging player in this fight against chronic condition

• In a short period of time, Vylda and Vylda M have been ranked # 4 amongst all Vildagliptin brands in the country

Anti-infective

Largest portfolio with best-in-class medicines

• Zostum is one of 8 brands listed in the top 300 brands of IPM

Respiratory

Differentiated portfolio aiding growth

CNS

Bringing innovation for stroke

• Tenectase is a pioneering brand used in the treatment of Acute ischemic stroke
• Emerging focus area for Emcure driven by its biologics portfolio along with other formulations

Nephrology

• Dynulta, the only Sucorferric Oxyhrodroxide available in the country in this category